Mona Shahriari

The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists

Lila T. Worden, Mona Shahriari, Andrew M. Farrar et al. · Psychopharmacology · 2008 · 78 citations · Full text

Dopamine Blockade, Differential Interaction, Functional Selectivity +10

Introduction of a mathematical model for optimizing the drug release in the patient’s body

Mohammad Reza Nabatchian, Hamid Shahriari, Mona Shahriari · DARU Journal of Pharmaceutical Sciences · 2014 · 68 citations · Full text

Pharmacokinetic Modeling, Pharmacology, Drug Delivery Systems +8

Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial

Ali Ghaleiha, Rosa Alikhani, Mohammad-Reza Kazemi et al. · Journal of Child and Adolescent Psychopharmacology · 2016 · 46 citations

The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade

Lyndsey E. Collins, Thomas N. Sager, Anette Sams et al. · Pharmacology Biochemistry and Behavior · 2011 · 42 citations

Health Sciences, Functional Selectivity, Addiction +10

Thyroid Papillary Microcarcinoma: Etiology, Clinical Manifestations,Diagnosis, Follow-up, Histopathology and Prognosis.

Shiva Dideban, Alireza Abdollahi, Alipasha Meysamie et al. · PubMed · 2016 · 32 citations · Full text